4//SEC Filing
Kastelein Johannes Jacob Pieter 4
Accession 0000950170-25-111241
CIK 0001936258other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 5:04 PM ET
Size
9.5 KB
Accession
0000950170-25-111241
Insider Transaction Report
Form 4
Kastelein Johannes Jacob Pieter
DirectorChief Scientific Officer
Transactions
- Sale
Ordinary Shares
2025-08-22$25.08/sh−42,342$1,061,937→ 76,960 total(indirect: See footnote) - Sale
Ordinary Shares
2025-08-21$24.29/sh−50,000$1,214,500→ 119,302 total(indirect: See footnote) - Sale
Ordinary Shares
2025-08-22$25.49/sh−7,658$195,202→ 69,302 total(indirect: See footnote)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.73 per share to $24.57 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction.
- [F2]The ordinary shares are held by Futurum B.V. ("Futurum") for the benefit of the Reporting Person. The Reporting Person exercises sole voting and investment control over the ordinary shares held by Futurum.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.39 per share to $25.35 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.39 per share to $25.62 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction.
Documents
Issuer
NewAmsterdam Pharma Co N.V.
CIK 0001936258
Entity typeother
Related Parties
1- filerCIK 0002000389
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 5:04 PM ET
- Size
- 9.5 KB